Skip to content
Thomson Reuters
Health

Britain’s sugar tax on soft drinks comes into effect

Reuters Staff

06 Apr 2018

By Reuters Staff | 6 April 2018

LONDON (Reuters) – Britain’s sugar tax on soft drinks came into effect on Friday, a move that will lead to some higher prices as the country seeks to battle childhood obesity.

The tax, announced in March 2016, has already cut sugar content in drinks by 45 million kg per year, Britain’s Treasury said, as over 50 percent of manufacturers have reformulated their products to be below the levy’s sugar threshold.

“Our teenagers consume nearly a bathtub of sugary drinks each year on average, fuelling a worrying obesity trend in this country,” Public Health Minister Steve Brine said.

“The soft drinks industry levy is ground-breaking policy that will help to reduce sugar intake, whilst funding sports programs and nutritious breakfast clubs for children.”

Because of the reformulations, the Treasury now expects the levy to raise only about 240 million pounds ($336 million) in its first year, less than half of its prior forecast of 520 million.

Soft drink makers including Coca-Cola, Britvic and Lucozade Ribena Suntory have reformulated drinks, though Coca-Cola Classic, the nation’s top-selling branded soft drink, is subject to the tax.

Retailers Tesco, Asda and Morrisons have also reformulated their own-label fizzy drinks to be below the levy’s threshold.

Reporting by Martinne Geller; Editing by Dale Hudson
Our Standards:The Thomson Reuters Trust Principles.
Robots fight weeds in challenge to agrochemical giants Australian scientist, 104, plans to kill himself with ‘Swiss option’ Delayed calorie disclosure rule takes effect for U.S. food sellers Scotland introduces minimum alcohol pricing to cut deaths Nepal’s medical drones bring healthcare to the Himalayas China’s Xuzhou shuts steel mills in pollution crackdown -sources Palm buyers urged to work on sustainability, not ban vegetable oil Global leaders seek to reignite fight against deadly malaria Industry fears disruption as EU excludes UK from drug approvals U.S. drug agency proposes rules to rein in opioid manufacturing